Share this article

The role of ALLEVYN™ Ag in the management of hard-to-heal wounds

John Lantis
18 November 2011

<p>Hard-to-heal wounds are challenging to treat and have a significant impact on a patient’s quality of life and healthcare resources [1,2,3]. For clinicians, hard-to-heal wounds pose the dual challenge of providing cost-effective management, while improving patients’ wellbeing and concordance with treatment [1,4,5]. This paper examines the impact of hard-to-heal wounds on patients and reviews the clinical efficiency and cost-effectiveness of a topical antibacterial dressing containing silver sulfadiazine (ALLEVYN™ Ag, Smith & Nephew) in the management of patients with infected hard-to-heal wounds.</p>

Free for all healthcare professionals

Sign up to the Wounds Group journals

By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.